9EUO image
Entry Detail
PDB ID:
9EUO
EMDB ID:
Title:
Outward-open structure of Drosophila dopamine transporter bound to an atypical non-competitive inhibitor
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2024-03-27
Release Date:
2024-07-24
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Sodium-dependent dopamine transporter
Mutations:V74A, V275A, V311A, L415A, G538L, delta 1-20, delta 164-206
Chain IDs:A
Chain Length:543
Number of Molecules:1
Biological Source:Drosophila melanogaster
Polymer Type:polypeptide(L)
Description:9D5 ANTIBODY, HEAVY CHAIN
Chain IDs:C (auth: H)
Chain Length:240
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:9D5 ANTIBODY, LIGHT CHAIN
Chain IDs:B (auth: L)
Chain Length:237
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site.
J.Neurochem. 168 2043 2055 (2024)
PMID: 39010681 DOI: 10.1111/jnc.16179

Abstact

The regulation of dopamine (DA) removal from the synaptic cleft is a crucial process in neurotransmission and is facilitated by the sodium- and chloride-coupled dopamine transporter DAT. Psychostimulant drugs, cocaine, and amphetamine, both block the uptake of DA, while amphetamine also triggers the release of DA. As a result, they prolong or even amplify neurotransmitter signaling. Atypical inhibitors of DAT lack cocaine-like rewarding effects and offer a promising strategy for the treatment of drug use disorders. Here, we present the 3.2 Å resolution cryo-electron microscopy structure of the Drosophila melanogaster dopamine transporter (dDAT) in complex with the atypical non-competitive inhibitor AC-4-248. The inhibitor partially binds at the central binding site, extending into the extracellular vestibule, and locks the transporter in an outward open conformation. Our findings propose mechanisms for the non-competitive inhibition of DAT and attenuation of cocaine potency by AC-4-248 and provide a basis for the rational design of more efficacious atypical inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures